Byonyks Factory, established in 2021, is Pakistan's first DRAP-approved and ISO 13485-certified dialysis device manufacturing unit. This pioneering facility represents a significant milestone in the country's healthcare sector, specializing in the production of high-quality bloodless dialysis devices. With a focus on innovation and patient care, Byonyks Factory plays a key role in addressing the growing demand for dialysis solutions, setting new standards in medical device manufacturing.

The Byonyks R&D Facility, located in DHA Phase 3, is at the forefront of medical innovation in Pakistan. Dedicated to advancing healthcare solutions, this state-of-the-art research and development center focuses on pioneering breakthroughs in dialysis technology. By fostering collaboration between skilled engineers and medical professionals, the facility drives the development of cutting-edge, patient-centric products designed to transform kidney care globally.

Welcome to the Visitor Gallery, where we showcase memorable moments from visits to our cutting-edge R&D facility. This gallery highlights interactions with healthcare professionals, industry leaders, and esteemed guests who have toured our state-of-the-art center in DHA Phase 3. Each visit reflects Byonyks' commitment to transparency, innovation, and collaboration in the development of groundbreaking dialysis technology. Explore the insights and exchanges that shape our mission to revolutionize kidney care both locally and globally.

At Byonyks, our Medical Training Sessions go beyond just teaching – they’re about empowering healthcare professionals to make a real difference in patients' lives. These sessions provide hands-on experience with our bloodless APD machine, guided by experts who are passionate about improving kidney care. It’s a space where doctors, nurses, and technicians come together, learn, and share ideas, all with one goal in mind: to offer patients a better, more comfortable dialysis experience. Together, we’re building a future where innovative care transforms lives, one patient at a time.